...
atos-img

Atossa Genetics Inc, Common Stock

ATOS

NAQ

$1.07

-$0.05

(-4.46%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$140.90M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.20M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.23
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.7 L
$2.31 H
$1.07

About Atossa Genetics Inc, Common Stock

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameATOSSectorS&P500
1-Week Return-14.4%-3.72%-0.05%
1-Month Return-16.41%-1.85%2.75%
3-Month Return-29.14%-11.4%7.4%
6-Month Return-6.96%-4.41%10.47%
1-Year Return48.59%4.13%27.57%
3-Year Return-43.68%0.3%29.56%
5-Year Return-23.02%36.62%89.3%
10-Year Return-99.37%106.81%206.09%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue52.79K46.60K23.00K8.00K23.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":88.28,"profit":true},{"date":"2021-12-31","value":43.57,"profit":true},{"date":"2022-12-31","value":15.15,"profit":true},{"date":"2023-12-31","value":43.57,"profit":true}]
Gross Profit(52.79K)(46.60K)(23.00K)(8.00K)(23.00K)[{"date":"2019-12-31","value":-5278900,"profit":false},{"date":"2020-12-31","value":-4660000,"profit":false},{"date":"2021-12-31","value":-2300000,"profit":false},{"date":"2022-12-31","value":-800000,"profit":false},{"date":"2023-12-31","value":-2300000,"profit":false}]
Gross Margin-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses17.27M14.61M20.52M27.69M31.38M[{"date":"2019-12-31","value":55.03,"profit":true},{"date":"2020-12-31","value":46.55,"profit":true},{"date":"2021-12-31","value":65.4,"profit":true},{"date":"2022-12-31","value":88.25,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(17.27M)(14.61M)(20.52M)(27.69M)(31.38M)[{"date":"2019-12-31","value":-1726542500,"profit":false},{"date":"2020-12-31","value":-1460739200,"profit":false},{"date":"2021-12-31","value":-2052100000,"profit":false},{"date":"2022-12-31","value":-2769100000,"profit":false},{"date":"2023-12-31","value":-3137700000,"profit":false}]
Total Non-Operating Income/Expense25.65K(4.16M)(79.00K)1.61M5.06M[{"date":"2019-12-31","value":0.51,"profit":true},{"date":"2020-12-31","value":-82.21,"profit":false},{"date":"2021-12-31","value":-1.56,"profit":false},{"date":"2022-12-31","value":31.78,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(17.24M)(17.83M)(20.61M)(26.96M)(30.09M)[{"date":"2019-12-31","value":-1723977700,"profit":false},{"date":"2020-12-31","value":-1782795200,"profit":false},{"date":"2021-12-31","value":-2060600000,"profit":false},{"date":"2022-12-31","value":-2696000000,"profit":false},{"date":"2023-12-31","value":-3009400000,"profit":false}]
Income Taxes(119.07K)3.27M(213.56K)(731.00K)-[{"date":"2019-12-31","value":-3.64,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-6.53,"profit":false},{"date":"2022-12-31","value":-22.35,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(17.12M)(21.10M)(20.39M)(26.23M)-[{"date":"2019-12-31","value":-1712070600,"profit":false},{"date":"2020-12-31","value":-2109931300,"profit":false},{"date":"2021-12-31","value":-2039244200,"profit":false},{"date":"2022-12-31","value":-2622900000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(17.24M)(17.83M)(20.61M)(26.96M)(29.83M)[{"date":"2019-12-31","value":-1723977700,"profit":false},{"date":"2020-12-31","value":-1782795200,"profit":false},{"date":"2021-12-31","value":-2060600000,"profit":false},{"date":"2022-12-31","value":-2696000000,"profit":false},{"date":"2023-12-31","value":-2983100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(17.24M)(21.10M)(20.61M)(26.23M)(30.09M)[{"date":"2019-12-31","value":-1723977700,"profit":false},{"date":"2020-12-31","value":-2109931300,"profit":false},{"date":"2021-12-31","value":-2060600000,"profit":false},{"date":"2022-12-31","value":-2622900000,"profit":false},{"date":"2023-12-31","value":-3009400000,"profit":false}]
EPS (Diluted)(2.04)(1.97)(0.18)(0.21)(0.27)[{"date":"2019-12-31","value":-204,"profit":false},{"date":"2020-12-31","value":-197,"profit":false},{"date":"2021-12-31","value":-18,"profit":false},{"date":"2022-12-31","value":-21,"profit":false},{"date":"2023-12-31","value":-27,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ATOS
Cash Ratio 12.90
Current Ratio 13.30

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ATOS
ROA (LTM) -20.35%
ROE (LTM) -31.30%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ATOS
Debt Ratio Lower is generally better. Negative is bad. 0.07
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.93

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ATOS
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.91
Price/FCF NM
EV/R 0.00
EV/Ebitda 2.01
PEG NM

FAQs

What is Atossa Genetics Inc share price today?

Atossa Genetics Inc (ATOS) share price today is $1.07

Can Indians buy Atossa Genetics Inc shares?

Yes, Indians can buy shares of Atossa Genetics Inc (ATOS) on Vested. To buy Atossa Genetics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ATOS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Atossa Genetics Inc be purchased?

Yes, you can purchase fractional shares of Atossa Genetics Inc (ATOS) via the Vested app. You can start investing in Atossa Genetics Inc (ATOS) with a minimum investment of $1.

How to invest in Atossa Genetics Inc shares from India?

You can invest in shares of Atossa Genetics Inc (ATOS) via Vested in three simple steps:

  • Click on Sign Up or Invest in ATOS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Atossa Genetics Inc shares
What is Atossa Genetics Inc 52-week high and low stock price?

The 52-week high price of Atossa Genetics Inc (ATOS) is $2.31. The 52-week low price of Atossa Genetics Inc (ATOS) is $0.7.

What is Atossa Genetics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Atossa Genetics Inc (ATOS) is

What is Atossa Genetics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Atossa Genetics Inc (ATOS) is 1.91

What is Atossa Genetics Inc dividend yield?

The dividend yield of Atossa Genetics Inc (ATOS) is 0.00%

What is the Market Cap of Atossa Genetics Inc?

The market capitalization of Atossa Genetics Inc (ATOS) is $140.90M

What is Atossa Genetics Inc’s stock symbol?

The stock symbol (or ticker) of Atossa Genetics Inc is ATOS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top